Fundamentun, LLC Eli Lilly & CO Transaction History

Fundamentun, LLC

$1.34 Billion
Q3 2024

A detailed history of Fundamentun, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fundamentun, LLC holds 6,910 shares of LLY stock, worth $5.17 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

6,910

Previous 6,864 0.67%

Holding current value

$5.17 Million

Previous $6.21 Million 1.5%

% of portfolio

0.46%

Previous 0.55%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$772.14 - $960.02 $35,518 - $44,160	46 Added 0.67%	6,910 $6.12 Million
Q2 2024 Jul 24, 2024	BUY	$724.87 - $909.04 $975,675 - $1.22 Million	1,346 Added 24.39%	6,864 $6.21 Million
Q1 2024 Apr 16, 2024	BUY	$592.2 - $792.28 $64,549 - $86,358	109 Added 2.02%	5,518 $4.29 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $65,648 - $77,391	125 Added 2.37%	5,409 $3.15 Million
Q3 2023 Oct 24, 2023	BUY	$434.7 - $599.3 $723,775 - $997,834	1,665 Added 46.01%	5,284 $2.84 Million
Q2 2023 Jul 18, 2023	BUY	$350.74 - $468.98 $42,790 - $57,215	122 Added 3.49%	3,619 $1.7 Million
Q1 2023 May 01, 2023	BUY	$310.63 - $364.82 $102,818 - $120,755	331 Added 10.45%	3,497 $1.2 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $108,683 - $126,638	-338 Reduced 9.65%	3,166 $0
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $200,420 - $228,400	-676 Reduced 16.17%	3,504 $1.13 Million
Q2 2022 Sep 06, 2022	SELL	$278.73 - $327.27 $6,410 - $7,527	-23 Reduced 0.55%	4,180 $1.36 Million
Q1 2022 Apr 26, 2022	BUY	$234.69 - $291.66 $33,325 - $41,415	142 Added 3.5%	4,203 $1.2 Million
Q4 2021 Jan 14, 2022	SELL	$224.85 - $279.04 $120,519 - $149,565	-536 Reduced 11.66%	4,061 $1.12 Million
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $512,560 - $630,778	2,313 Added 101.27%	4,597 $1.06 Million
Q2 2021 Jul 19, 2021	BUY	$180.55 - $233.54 $412,376 - $533,405	2,284 New	2,284 $524,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fundamentun, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fundamentun, LLC with notifications on news.

Account